HealthPro Direct, Inc.® "Turn Back The Clock"™
Seed Investor Presentation - Own a Part of a New Generation of ONLINE TeleMedicine
$250,000 Investment for 5% Equity - Proof Of Concept to Launch MensRx® & WomensRx®
Prepared for: Seed Investor
Founder & CEO: Glen Brosnick
Second Round Investment will be Guided under SEC Attorney Jay L. Valinsky who will create PPM
Next Funding in the Range between 30-50 Million Dollars
Schedule Investor Call
"We are building the first dual-gender wellness and lifestyle telehealth and Retail Empire"
Hair Loss
Clinical-strength solutions for pattern baldness and thinning
Hormone Replacement Therapy
Comprehensive optimization for vitality and performance
Sexual Wellness
Addressing intimacy and libido concerns head-on
Weight Loss
GLP-1 and peptide-based metabolic transformation
Peptides
Advanced longevity and recovery protocols
Youth Optimization
Complete vitality restoration systems
Anti-Aging
Comprehensive age-reversal and longevity protocols
Mental Wellness
Cognitive optimization and mental health support
Only ONE company in the U.S. owns BOTH the men's and women's vitality ​markets.
​​ Men + Women. Online + Retail. Hormones + Desire + Aesthetics.
No telehealth brand in the U.S. owns BOTH markets. We will — and this is the ground floor.
The Unsolved $50B Vitality Problem
More than 40 million Americans are actively struggling with debilitating vitality issues that traditional healthcare overlooks and mainstream telehealth platforms deliberately avoid. These aren't cosmetic concerns—they're life-altering conditions that destroy confidence, relationships, and quality of life.
Hair Loss
Devastating confidence across all ages
Hormone Collapse
Energy and vitality decline
Low Libido
Relationship strain and intimacy loss
Weight Gain
Metabolic dysfunction
Emotional Crash
Mood and mental clarity issues
Telehealth giants avoid the REAL problems. We solve them.
Founder & CEO — Glen Brosnick
Seasoned Healthcare Entrepreneur with a Proven 30+ Year Track Record in Pharmacy, Compounding, Telemedicine & Direct-to-Consumer Healthcare
Key Achievements & Expertise:
  • Serial Entrepreneurship & Company Building: Founded and successfully operated 10+ healthcare and DTC companies, including HealthPro Direct.
  • Pioneering Market Entry: Launched a national mail-order diabetic supply company in 2004, demonstrating early vision in direct-to-consumer healthcare.
  • Brand & Product Innovation: Founded MensRx® and WomensRx® in 2019, quickly developing proprietary clinical products such as MinoxPlus®, MinoxiPro®, GlowStax™, Glowbido™, and Glowvido™ (all registered trademarks).
  • Hair Loss Innovation Pioneer: Created the first 10% compounded minoxidil hair loss formulation in 2018
  • Strategic Medical Partnerships: Established the first trial mail-order pharmacy for hair loss medication and custom formalized MinoxPlus® treatment for renowned hair transplant surgeon Dr. Glenn Charles of Charles Medical Group in Boca Florida
  • Advanced Clinical Protocol Development: Spearheaded the development of cutting-edge GLP-1 programs, comprehensive hormone therapy solutions, and advanced sexual wellness protocols.
  • Executive Pharmaceutical Operations: Held executive leadership roles in highly regulated 503A and 503B compounding, infusion therapy, and nationwide home-delivery pharmacies.
  • Large-Scale Supply Chain & Distribution: Managed prescription medication production and distribution channels across all 50 states, ensuring broad market access.
  • Specialized Formulations & Manufacturing: Deep expertise in sterile injectables, custom formulations, and the production of Tirzepatide/Semaglutide injection pens.
  • DTC & Digital Growth Mastery: Proven proficiency in DTC operations, e-commerce, SEO, and building scalable membership models since 1996.
  • Visionary Leadership: Recognized as a Visionary Leader and adept Marketing Strategist, consistently driving market innovation and growth.
Robust Operational Infrastructure – Already Built & Fully Operational:
  • Comprehensive Telemedicine Platform: Established and fully integrated telemedicine platform with streamlined workflows.
  • Strategic Compounding Partnerships: Secured compounding partnerships and efficient fulfillment systems already in place.
  • Seamless EMR & Billing Systems: Integrated EMR and billing systems for optimized operational efficiency.
  • End-to-End Product Lifecycle Management: Proven capabilities in product development and stringent regulatory compliance.
Bottom Line: Glen Brosnick is the right leader at the right time. A proven CEO and healthcare operator with three decades of deep pharmacy experience and an unparalleled track record of execution across complex, regulated environments. The essential infrastructure is not just conceptual; it’s built, rigorously tested, and primed for immediate, impactful scale.
MensRx - mensrx.com
MensRx will be targeting the most underserved and profitable segments of male health. This isn't just testosterone replacement—it's a comprehensive vitality ecosystem designed for recurring revenue and exceptional retention.
Every product line is optimized for subscription economics with industry-leading margins. Men who start with one treatment inevitably add more, creating natural upsell pathways that drive lifetime value through the roof.
92%
Conversion Rate
From consultation to subscription
95%
Retention
Monthly subscriber retention rate
$3,089
LTV
Average customer lifetime value
MensRx Product Ecosystem
Six revenue streams, one integrated platform. Each product line stands alone profitably while driving cross-sell opportunities across the entire ecosystem. This is subscription medicine at its finest—solving real problems with premium solutions.
1
MinoxPlus® Hair Regrowth
8% prescription-strength topical formula delivering clinically proven results. Proprietary compound outperforms standard minoxidil with enhanced absorption technology.
2
MinoxiPro® Daily Support
Premium shampoo system with caffeine and nutrient complex. Complements topical treatments while generating standalone revenue from maintenance-focused customers.
3
TRT Optimization
Complete testosterone replacement therapy with comprehensive panel testing, physician oversight, and personalized dosing protocols for sustained vitality.
4
Peptide Therapy
CJC-1295, Ipamorelin, Sermorelin, and BPC-157 protocols for recovery, performance, anti-aging, and metabolic optimization.
5
GLP-1 Weight Loss
Semaglutide and Tirzepatide programs with medical monitoring, nutritional support, and proven protocols for sustainable weight management.
6
Performance Enhancement
ED solutions, energy optimization, and comprehensive male vitality protocols addressing the complete spectrum of performance concerns.
MensRx Hair Restoration Engine
Two-Tier Ecosystem Coverage
Our hair restoration system captures customers at every stage of hair loss, from early prevention to aggressive regrowth protocols. This tiered approach maximizes both customer acquisition and lifetime value.
1
MinoxiPro® Support Level
Entry point for prevention-minded customers. Lower price point, higher volume, strong retention. Builds brand loyalty before escalation needs.
2
MinoxPlus® Prescription Power
8% prescription formula for serious regrowth. Premium pricing justified by superior results. Natural upsell from support tier.
3
Advanced DHT Blockers
Finasteride and Dutasteride options for customers requiring comprehensive intervention. Highest revenue per customer segment.

Market Validation: Hair loss affects 50M+ American men. Current solutions are fragmented, low-quality, or prohibitively expensive. We offer medical-grade results at accessible subscription pricing.
MensRx Hormone & Metabolic Engine
TRT Panels
Comprehensive hormone testing with physician interpretation. Subscription model includes quarterly monitoring and dosage optimization.
Peptide Regimens
Customized peptide protocols targeting specific outcomes: muscle growth, fat loss, recovery, anti-aging, cognitive enhancement.
GLP-1 Programs
Medical-grade Semaglutide and Tirzepatide with comprehensive support systems. Highest demand category in telehealth today.
Metabolic Protocols
Integrated weight management combining medication, nutritional coaching, and metabolic optimization for sustainable results.
Sexual Vitality Stack
Comprehensive ED solutions integrated with hormone optimization. Addresses root causes rather than symptom masking.
TRT Clinic Economics: This is only 1 Example of Many Treatment Plans we will offer:
Market Validation: This economic model is not merely hypothetical; it's a proven playbook. Ageless Men's successful operation of 75 current locations, utilizing this exact model, unequivocally validates every financial assumption and operational metric presented. This robust TRT offering represents only one of the treatments that generate an impressive $2.85M in annual revenue and $2.59M in gross profit per clinic. Crucially, this represents just one treatment offering within our broader ecosystem, with additional services such as hair loss solutions, peptides, weight loss programs, and aesthetics providing significant supplemental revenue streams built upon this profitable foundation.

Strategic Insight: The formidable profitability of our TRT services establishes a high-margin foundation. This single revenue stream is a powerful anchor, demonstrating the core financial strength that supports MensRx's expansion into a comprehensive, multi-service telehealth ecosystem.
MensRx Total Addressable Market
We're entering three massive, proven markets with a single integrated platform. Each segment operates independently while creating powerful cross-sell dynamics that amplify customer lifetime value.
MensRx TAM = $24B+
Conservative capture of just 0.1% market share represents $24M in annual revenue. Our integrated platform approach positions us to capture significantly higher market share through superior customer experience and comprehensive solution offerings.
WomensRx womensrx.com
The Massive Underserved Opportunity
Women face a healthcare crisis that nobody is solving comprehensively. Low libido, menopause symptoms, mood instability, and hormone imbalances affect over 50 million American women—yet no brand offers an integrated, medical-grade, emotionally intelligent solution.
Current options are fragmented: OB/GYNs who dismiss symptoms, sketchy supplement companies making unverified claims, or expensive concierge services out of reach for most women. The market is screaming for a trusted, affordable, medically-backed brand that actually understands their needs.
67%
Women Experience Low Libido
At some point in their lives
75%
Menopause Symptoms
Severe enough to impact daily life
89%
Feel Dismissed
By traditional healthcare providers
GlowStax™: The Female Breakthrough
We've developed a proprietary dual-pathway system that addresses both the immediate emotional need (desire) and the underlying biochemical reality (hormone balance). This is the first product ecosystem designed specifically for female vitality that combines on-demand solutions with long-term optimization.
Glowbido™ Desire Pen
On-demand sublingual delivery system for immediate desire enhancement. Proprietary compound works within 15-30 minutes. Discreet, pharmaceutical-grade, physician-prescribed.
Glowvido™ Daily Stack
Comprehensive daily supplement targeting libido, mood stability, energy, and hormonal balance. Builds baseline vitality while complementing on-demand solutions.
Estrogen Optimization
Bioidentical hormone replacement options with physician oversight. Addresses root causes of menopause symptoms, mood instability, and vitality decline.
GLP-1 & Peptides
Medical weight management and metabolic optimization specifically dosed for female physiology. Integrated with hormone balancing for optimal results.
WomensRx Total Addressable Market
The female vitality market dwarfs the male market in both size and urgency. Women actively seek solutions, spend more on health and wellness, and demonstrate higher loyalty to brands they trust. Yet no major player has built a comprehensive telehealth platform specifically for them.
WomensRx TAM = $53B+
This market is growing 18% annually as societal stigma decreases and women demand better solutions. First-mover advantage in this space creates a defensible moat through brand trust and clinical credibility.
HoldCo/OpCo Structure: Asset Protection
Strategic Separation of Assets
We've structured the business to protect intellectual property and maximize strategic value. The HoldCo (HealthPro Direct IP, Inc.) owns all proprietary assets while the OpCo handles operational execution. This structure is standard in high-growth ventures for critical reasons.
Your equity stake is in HoldCo—the asset-holding entity that licenses IP to operations. This protects your investment from operational liabilities while capturing full enterprise value in any exit scenario.
HoldCo Owns
  • Proprietary formulations
  • MensRx & WomensRx trademarks
  • GlowStax™ intellectual property
  • Domain portfolio
  • Brand equity
OpCo Executes
  • Telehealth platform operations
  • Customer acquisition
  • Fulfillment & logistics
  • Pharmacy partnerships
  • Clinical oversight

Exit Advantage: This structure increases valuation multiples by isolating high-value IP assets. Strategic acquirers pay premium multiples for clean IP portfolios separate from operational complexity.
Infrastructure Fully Built
Unlike most early-stage ventures seeking funding to "figure it out," we've already built, tested, and validated the entire operational infrastructure. Your capital deploys immediately into customer acquisition and scaling—not into building systems or hoping things work.
01
Pharmacy Partnerships Secured
Multi-state licensed pharmacy network with 503B compounding capabilities. All regulatory approvals in place for immediate nationwide service.
02
Telehealth Platform Live
50-state compliant telemedicine infrastructure with EMR integration, automated physician routing, and seamless prescription fulfillment.
03
Billing & Operations
Payment processing, subscription management, insurance verification, and customer support systems fully operational and tested.
04
Marketing Infrastructure
Conversion-optimized funnels, UGC content library, email sequences, and retention automation ready to scale with advertising spend.
05
Fulfillment Systems
Inventory stocked, shipping partnerships established, packaging designed. First orders ship within 48 hours of capital deployment.
"Most telehealth startups spend 12-18 months building what we've already completed. Your capital accelerates growth, not construction."
Competitive Subscription Advantage
We've engineered a membership model that generates 3-4x more revenue per customer than competitors while delivering superior value. This isn't about charging more—it's about solving more problems comprehensively.
Hims/Hers Approach
Basic model: $20-30/month
Single-issue focus
No comprehensive care
Limited product ecosystem
Low engagement
$25
Average ARPU
Revenue per user per month
68%
Gross Margin
Industry standard margins
$17
Gross Profit
Per subscriber monthly
HealthPro Approach
Comprehensive membership:
$39 base + $20 premium tier
Multiple treatment pathways
Integrated solutions
High engagement & retention
$198
Blended ARPU
Revenue per user per month
78%
Gross Margin
Premium product margins
$154
Gross Profit
Per subscriber monthly
We generate 9x more gross profit per customer than competitors while delivering objectively superior outcomes through comprehensive care. This isn't a margin play—it's a value creation model that customers eagerly pay for.
The Retention Engine: 95% Monthly Retention
In subscription businesses, retention is everything. Our 95% monthly retention rate isn't aspirational—it's validated through our existing customer base. When customers see real results from medical-grade solutions, they don't cancel.
1
Acquire Once
CAC = $100
One-time customer acquisition cost through optimized digital channels
2
Retain Forever
95% Monthly
Industry-leading retention driven by real results and comprehensive care
3
Compound Value
20 Month Lifespan
Average customer lifetime before natural attrition

The LTV Calculation
Monthly Revenue: $198
Gross Margin: 78%
Gross Profit per Month: $154.44
Average Lifespan: 20 months
LTV = $3,089
Customer Acquisition Cost: $100
LTV:CAC = 30.8x
Venture capitalists consider 3:1 LTV:CAC healthy. SaaS companies target 5:1. We deliver 30:1—unprecedented in healthcare or subscription models. This is the economic engine that powers exponential scaling.
36-Month Financial Outlook
These projections assume conservative customer acquisition rates and make no allowance for retail expansion, strategic partnerships, or product line extensions. Pure subscription telehealth growth alone creates a compelling investment thesis.
Year 1: Foundation
Telehealth: $12M (3K-8K subscribers)
5 Pilot Clinics: $14.25M TRT Revenue
Combined: $26.25M Revenue
Establish market presence, validate unit economics at scale, achieve operational profitability by Q4, and launch initial pilot clinics.
Year 2: Acceleration
Telehealth: $30M (15K subscribers)
25 Clinics: $71.25M TRT + Additional Services
Combined: $125M Revenue
Compound subscriber base, optimize CAC channels, expand product lines, and accelerate clinic expansion across key regions.
Year 3: Domination
Telehealth: $50M (25K subscribers)
50 Clinics: $217.5M Total Clinic Revenue
Combined: $267.5M Revenue
Combined Net Profit: $180M+
Achieve market leadership, solidify dual-platform dominance, and position for strategic acquisition by major players.
Retention + subscription economics = exponential scaling. Every cohort acquired continues generating profit while new cohorts layer on top. This is the compounding machine that creates venture returns.
This aggressive yet conservative model is validated by industry leaders like Ageless Men's, who have successfully scaled to 75 clinic locations. Our projected clinic rollout is deliberately more conservative than their proven growth trajectory, minimizing risk while maximizing upside.
Break-Even Timeline
1,850
Subscribers to Break-Even
Projected achievement: Month 9–11
After break-even, every new subscriber generates pure recurring profit minus low variable product costs. The business becomes a cash-generating machine.
1
Months 1-3
Initial customer acquisition, infrastructure optimization, early cohort validation
2
Months 4-6
Scaling acquisition channels, retention cohorts maturing, operational leverage improving
3
Months 7-9
Approaching break-even, multiple cohorts compounding, CAC optimization complete
4
Months 10-12
Profitability achieved, scaling accelerates, retail planning begins

Capital Efficiency: Most venture-backed companies burn through multiple funding rounds before profitability. We achieve break-even on seed capital—everything after is exponential growth.
Month 12 Snapshot: Profitability Achieved
By month 12, the business transitions from growth investment to cash-generating asset. These aren't projections pulled from thin air—they're mathematical outcomes of proven unit economics applied at modest scale.
8000
Telehealth Subscribers
Continuing to grow rapidly
33.25M
Total Annual Revenue
From telehealth and clinics
27M
Total Annual Gross Profit
Strong margins across services
20M
Total Annual Net Profit
After all operating costs
60%
Overall Profit Margin
Demonstrating efficiency

Revenue Composition (Annualized)
  • Telehealth Platform:
    - Revenue: $16.0M
    - Gross Profit: $12.0M
  • MensRx Clinics (5 Pilot Locations):
    - TRT Revenue: $14.25M
    - Additional Services Revenue: $3.0M
    - Total Clinic Gross Profit: $15.0M
    - Net Clinic Profit (after operating costs): $12.0M
Diversified revenue streams from both the telehealth platform and physical clinics create robust, compounding growth opportunities.
Path Forward
From month 12 onward, the business self-funds expansion. Every dollar of profit can be reinvested into acquisition, creating an accelerating flywheel. External capital becomes optional for growth.
At this point, we're not a startup. We're a profitable, scaling machine.

Scalability Potential: These impressive results are based on just 5 pilot clinic locations, compared to competitors like Ageless Men's Health operating 75+ locations. This demonstrates massive potential for expansion and market capture.
Phase 2: Retail Dominance
200 Walk-In Wellness Centers
100 MensRx + 100 WomensRx locations across all 50 states
While competitors remain trapped online, we're building the first national dual-gender wellness chain. These aren't traditional medical offices—they're premium branded destinations designed specifically for their target gender, offering services that telehealth simply cannot deliver.
Injectable Therapies
Testosterone, peptides, B-vitamins, NAD+, aesthetic injectables administered by licensed professionals
Laser Treatments
Hair restoration, skin rejuvenation, body contouring—90%+ margin services driving clinic profitability
HRT Programs
In-person hormone optimization with comprehensive monitoring, superior to telehealth-only approaches
Weight Management
GLP-1 programs with in-person support, nutrition coaching, body composition analysis
What Hims/Hers Cannot Do
Their Limitations
100% Digital Only
Cannot offer in-person services regardless of patient needs or preferences
No Injectables
Missing entire categories of high-margin treatments that require in-person administration
No Laser Services
Excluded from aesthetic services market entirely—billions in revenue inaccessible
Limited HRT Scope
Cannot provide comprehensive hormone management requiring regular monitoring
No Physical Presence
Zero brand visibility in communities, no local marketing opportunities, no walk-in traffic
Our Advantages
We capture revenue at every customer touchpoint—online convenience for medications plus in-person premium services for treatments requiring clinical administration. This omnichannel approach creates multiple revenue streams per customer while building local brand authority impossible for digital-only competitors.
We dominate both the digital AND physical wellness space. When customers need more than pills in a box, they'll already be in our ecosystem, ready to upgrade to in-clinic services.
The Male Aesthetic Gap
Men represent a massive untapped opportunity in aesthetic and wellness services. Currently, they face an uncomfortable choice: use feminized medspas where they feel out of place, or settle for clinical TRT mills that offer no aesthetic services. Nobody has built premium wellness destinations specifically for men.
"Men spend $30B+ annually on grooming, fitness, and wellness. They desperately want premium destinations designed for them—nobody is providing it at scale. We will own this category."
Retail Membership Economics
Clinic profitability starts with membership revenue—predictable, recurring income that covers fixed costs before selling a single service. This model transforms clinics from transaction-based businesses into subscription assets with compounding value.
Basic Tier
$49/month
  • Quarterly health screenings
  • 10% service discounts
  • Priority scheduling
  • Wellness consultations
Advanced Tier
$99/month
  • Monthly lab work included
  • 20% service discounts
  • Free vitamin injections
  • Nutrition planning
Elite Tier
$149/month
  • Comprehensive monitoring
  • 30% service discounts
  • Concierge access
  • Advanced treatments included

$87
Blended ARPU
Average revenue per member monthly across all tiers
200
Members Per Clinic
Conservative target for each location at maturity
$17,400
Monthly Base Revenue
Predictable income before any services sold
$208K
Annual Membership Revenue
Per clinic from subscriptions alone
Membership revenue alone makes clinics cashflow positive. Everything else—injectables, lasers, treatments—is pure upside driving profitability to extraordinary levels.
In-Clinic Revenue Stack
Each clinic operates as a diversified revenue center with 12+ income streams. Unlike traditional medical practices dependent on insurance reimbursement, we capture high-margin cash-pay services across multiple categories.
Injectable Therapies
TRT, peptides, vitamin IVs, B-complex shots—$50-200 per service, administered weekly or monthly for recurring revenue.
Laser Treatments
Hair restoration, skin rejuvenation, tattoo removal, body contouring—$200-1,000 per session, industry-leading margins.
Hormone Optimization
Comprehensive panels, pellet therapy, ongoing monitoring—$300-800 per protocol, high retention rates.
Peptide Protocols
Anti-aging, recovery, performance enhancement—$250-600 monthly for protocol packages.
Weight Management
GLP-1 programs, body composition, nutritional support—$400-800/month for comprehensive packages.
IV Therapy
Hydration, NAD+, vitamin infusions—$125-400 per session, quick high-margin services.
Medical Skincare
Professional-grade retail products—80-90% margins on curated product lines.
Specialty Consults
Sexual health, performance optimization, longevity planning—$150-300 per consultation.
Customers typically engage 2-3 service categories simultaneously, creating natural cross-sell dynamics that dramatically increase per-customer value beyond membership fees.
Profit Margins by Category
These aren't theoretical margins—they're industry standards for cash-pay aesthetic and wellness services. Traditional medical practices dream of these economics, constrained by insurance reimbursement. We operate in a cash-pay paradigm with premium pricing power.
Laser Services
90-95% Margin
Equipment cost amortized over thousands of treatments. Consumable costs minimal. Pure profit after equipment ROI.
Injectable Therapies
70-85% Margin
Compound pharmacies provide low-cost medications. Professional administration commands premium pricing. Recurring revenue model.
Hormone Programs
75% Margin
Medication costs low, monitoring protocols high-margin, long-term retention creates compounding value.
Retail Products
80-90% Margin
Medical-grade skincare at professional pricing. Passive revenue, zero labor cost, pure margin expansion.
Blended service margin across all categories: 78-82%. Compare this to traditional medical practices at 30-40% or retail businesses at 40-50%. This is why wellness clinics command premium valuation multiples.
Corporate Clinic Expansion Strategy: The Proprietor Model
Our strategy focuses exclusively on corporate-owned clinic expansion, allowing us to maintain full control and maximize profitability across all locations. We leverage a proven "Proprietor Model" for scalable, consistent growth.
The Proprietor Model (Outback Steakhouse System)
We DO NOT franchise. We DO NOT give up control. We maintain 100% brand consistency across medical protocols, hormone dosing, aesthetics, membership systems, pricing, patient experience, and brand standards.
How The Proprietor Model Works:
  • Corporate Owns the Clinic - Corporate controls medical compliance, operations, margins, products, staffing, technology, marketing
  • Proprietor Invests Small Stake - $25K-$50K personal buy-in creates extreme accountability, personal ownership, excellence in service, long-term loyalty
  • Proprietor Receives Profit Share - 8-10% of net clinic profits (industry norm 6-12% depending on margin structure)
Corporate Maintains:
  • 100% equity
  • 100% brand control
  • 100% operational control
Proprietor Receives:
  • Profit share ONLY
  • NO equity
  • NO brand rights
  • NO ability to replicate
  • NO ability to deviate from protocols
Why This Beats Franchising:
  • Faster Expansion (no franchise legal overhead, regulatory delays, inconsistent operators)
  • Higher Profit Retention (corporate keeps majority of profits)
  • Consistent Medical Quality (critical in healthcare - franchising is risky with medical compliance)
  • Better Talent Recruitment (NPs, injectors, medical directors prefer TRUE upside vs salary)
  • Brand Integrity Stays Perfect (every clinic identical across all 50 states)
Financial Projections:
  • Phase 1: 10-20 proprietor-led locations (Years 1-2)
  • Phase 2: Scale to 100 corporate-owned, proprietor-operated locations (Years 3-5)
  • Investment per clinic: $500K-750K
  • Proprietor contribution: $25K-$50K per clinic
  • Corporate retains: 90-92% of clinic profits
  • Network profit potential: $290M+ annually
The Future of Modern Wellness Centers are about to Arrive

This model is proven in restaurants, fitness, medspa chains, dental groups, and concierge clinics.
Revenue Per Clinic
Clinic economics vary by location, market maturity, and local competition. We model three scenarios based on comparable wellness center performance data. Even conservative projections deliver exceptional returns.
Conservative Scenario
$2.85M Annual TRT Revenue
  • TRT gross profit: $2.59M annually
  • Operating costs: $600K annually
  • Net profit from TRT alone: $1.99M per clinic
Base Case Scenario
$4.35M Annual Total Revenue
  • TRT revenue: $2.85M
  • Additional services (hair, peptides, aesthetics): $1.5M
  • Total gross profit: $3.7M (85% blended margin)
  • Operating costs: $800K
  • Net profit: $2.9M per clinic
Aggressive Scenario
$5.35M Annual Total Revenue
  • TRT revenue: $2.85M
  • Additional services: $2.5M
  • Total gross profit: $4.6M (86% blended margin)
  • Operating costs: $1M
  • Net profit: $3.6M per clinic

100 MensRx clinics × $2.9M average = $290M Annual Profit
Even if half of locations perform at conservative levels, the clinic network generates $80M+ in annual profit. This is Phase 2 alone—pure additive profit on top of the telehealth subscription base generating $30M+ annually by Year 3.
This is based on Ageless Men's proven 75-location model, scaled to our 100-clinic target.
Combined Online + Retail TAM
We're not building a telehealth company OR a clinic chain. We're building the first integrated platform that dominates both, capturing customers wherever they prefer to engage while maximizing lifetime value through cross-platform services.
$137B
Combined Total Addressable Market
Telehealth TAM: $50B
Male/female vitality, hormones, sexual health, weight management—accessible nationwide from day one
Retail TAM: $87B
Injectables, aesthetics, hormone clinics, medspas—services requiring physical locations and professional administration
Capturing just 0.1% of this combined market represents $137M in annual revenue. Our integrated model positions us to capture significantly more by owning customer relationships across both channels.
Investor ROI Projection
Your seed investment of $250K for 5% equity positions you for extraordinary returns across multiple realistic exit scenarios. Dual-platform healthcare companies with subscription revenue and physical assets command premium acquisition multiples.
Exit Comparables
Recent healthcare/wellness exits demonstrate the multiples strategic acquirers pay for businesses with our profile:
  • Hims & Hers IPO: $1.6B valuation (6x revenue)
  • Ro Health: $5B valuation (8x revenue)
  • Thirty Madison: $1B valuation (10x revenue)
  • Hand & Stone (franchise wellness): $250M+ (12x EBITDA)
We combine telehealth's high multiples with retail's stable cashflows—a premium positioning for strategic acquisition.
1
2
3
4
1
$100M Exit
5% stake = $5M return
20× return on $250K investment
Conservative scenario: Year 3-4 based on telehealth alone
2
$200M Exit
5% stake = $10M return
40× return on $250K investment
Base case: Year 4-5 with initial retail footprint
3
$400M Exit
5% stake = $20M return
80× return on $250K investment
Aggressive: Year 5-6 with scaled clinic network
4
$750M+ Exit
5% stake = $37.5M+ return
150×+ return on $250K investment
Exceptional: Full dual-platform dominance, IPO or strategic
"Strategic acquirers will pay premium multiples for the only dual-gender, omnichannel platform in vitality healthcare. You're investing at the absolute ground floor before anyone else sees what we're building."
The Investment Ask
$250,000
Seed Investment
5% Equity
$5M Post-Money Valuation
Capital Deployment (Founder's Proof of Concept Investment)
Every dollar goes directly into scaling proven economics. Infrastructure is built, products are formulated, systems are operational. This capital accelerates customer acquisition and market capture.
01
Customer Acquisition: $120K
Digital marketing, funnel optimization, initial customer cohorts across MensRx and WomensRx platforms. Proven $100 CAC delivers immediate returns.
02
Legal & Professional Services: $60K
  • Legal fees for corporate structure
  • Legal fees for telemedicine Attorneys
  • Legal fees for Trademark Attorney
  • Legal fees for PPM attorney
  • Accounting and bookkeeping firm
03
Inventory & Fulfillment: $40K
Product inventory to support first 6 months of growth. Packaging, shipping materials, pharmacy partnerships scaled for volume.
04
Team Expansion: $20K
Customer success, clinical oversight, operations support. Building capacity for 2,000+ subscribers without service degradation.
05
Working Capital & Reserve: $10K
Cash buffer for unexpected opportunities or operational needs. Conservative financial management.

Timeline to Next Raise: Based on our projections, we'll achieve profitability before requiring additional capital. Series A will be raised from strength, not necessity, to accelerate retail expansion.
"This is the model, the moment, and the execution plan."
You're seeing the full vision before the world does. The infrastructure is built. The market is massive and underserved. The economics are proven. The team is executing.
Dominating the Competitive Landscape
This isn't a pitch for potential—it's an invitation to participate in inevitable market dominance. While competitors stay confined to their lanes, we're building the first true vitality empire.
Our Integrated Vitality Empire

Contact
Glen Brosnick
Founder & CEO
HealthPro Direct, Inc.